The global transdermal patches market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The market is expected to increase, owing to the efficacy of transdermal patches in addressing difficulties and growing applications. Transdermal Patches are a type of patch that adheres to the skin and delivers medication to the body through it. It does not use sirens or other materials that must be injected into the body, however, instead uses glue that adheres to the skin, making it simple to put and remove.
Furthermore, the advantages of these patches, such as the painless administration of medicine and the drug’s prolonged activity, make them popular, particularly among the elderly and youth. Pain treatment transdermal patches are used globally to relieve joint, muscle, and other types of pain. Due to an increase in the number of people quitting smoking, the global market is likely to grow in the future years. The demand for nicotine patches and nicotine replacement therapy is predicted to increase as the smoking rate declines. In the next years, this will result in a boom in transdermal patch sales. According to the Centers for Disease Control and Prevention, 7.5% of adult smokers, or about 2.9 million people, were successful in quitting smoking in 2018. When attempting to quit smoking, 31.2% of all adult smokers said they received medication and counseling.
To Request a Sample of our Report on Transdermal Patches Market: https://www.omrglobal.com/request-sample/transdermal-patches-market
The major companies serving the global transdermal patches market include Novartis AG, Fierce Pharma, 3M, Aveva, Teva Pharmaceutical Industries Ltd., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2021, ImQuest Biosciences has announced the launch of an antiretroviral (ARV) transdermal delivery patch. This patch was developed to replace oral medication for HIV patients.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Novartis AG, Fierce Pharma, 3M, Aveva, Teva Pharmaceutical Industries Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Transdermal Patches Market is Available @ https://www.omrglobal.com/industry-reports/transdermal-patches-market
Global Transdermal Patches Market Report Segment
By Type
- Single-layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Matrix
By Application
- Pain Relief
- Smoking Reduction and Cessation Aid
- Overactive Bladder
- Hormonal Therapy
Global Transdermal Patches Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Acrux Limited
- Agile Therapeutics Inc.
- Cipla Inc.
- Glenmark
- ImQuest Biosciences
- Luye Pharma Group
- Mylan N.V.
- Purdue Pharma L.P.
- Rusan Pharma
- Teikoku Pharma USA, Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
